Mahajan, Nupam P.
Coppola, Domenico
Kim, Jongphil
Lawrence, Harshani R.
Lawrence, Nicholas J.
Mahajan, Kiran
Article History
Received: 21 August 2017
Accepted: 15 January 2018
First Online: 31 January 2018
Competing Interests
: The Moffitt Cancer Center has filed patent as follows: “Inhibitors of ACK1/TNK2 Tyrosine Kinase” (patent no. 9,850,216). K.M., H.R.L., N.J.L., and N.P.M. are named as inventors on ACK1/TNK2 kinase inhibitors. The patent has been licensed by TechnoGenesys, Inc. K.M. and N.P.M. are co-founders of TechnoGenesys, Inc., own stock, and serve as consultants for TechnoGenesys, Inc.